研究单位：[1]Shanghai Jiaolian Drug Research and Development Co., Ltd[2]Shanghai Pharmaceuticals Holding Co., Ltd[3]Beijing Anzhen Hospital，Capital Medical University,Beijing,China[4]Beijing Tiantan Hospital，Capital Medical University,Beijing,China[5]Beijing Tongren Hospital, Capital Medical University,Beijing,China[6]Peking University First Hospital,Beijing,China[7]The First Medical Center of PLA General Hospital,Beijing,China[8]The Third Medical Center of PLA General Hospital,Beijing,China[9]The Second Xiangya Hospital of Central South University,Changsha,China[10]Xiangya Hospital Central South University,Changsha,China[11]Sichuan Provincial People''s Hospital,Chengdu,China[12]The First Affiliated Hospital of Fujian Medical University,Fuzhou,China[13]Guangzhou First People''s Hospital,Guangzhou,China[14]Sun Yat-sen Memorial Hospital, Sun Yat-sen University,Guangzhou,China[15]The First Affiliated Hospital, Sun Yat-sen University,Guangzhou,China[16]The Third Affiliated Hospital, Sun Yat-sen University,Guangzhou,China[17]Zhujiang Hospital of Southern Medical University,Guangzhou,China[18]The Affiliated Hospital of Guizhou Medical University,Guiyang,China[19]The Second Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou,China[20]The Fourth Affiliated Hospital of Harbin Medical University,Harbin,China[21]The Second Affiliated Hospital of Harbin Medical University,Harbin,China[22]Anhui Provincial Hospital,Hefei,China[23]The Second Affiliated Hospital of Anhui Medical University,Hefei,China[24]Huizhou First Hospital,Huizhou,China[25]The First Affiliated Hospital of Shandong First Medical University,Jinan,China[26]Affiliated Hospital of Jining Medical University,Jining,China[27]First Affiliated Hospital of Kunming Medical University,Kunming,China[28]First People''s Hospital of Yunnan Province,Kunming,China[29]Jiangxi Provincial People''s Hospital,Nanchang,China[30]Qilu Hospital of Shandong University (Qingdao),Qingdao,China[31]The First Hospital of China Medical University,Shenyang,China[32]Shenzhen Hospital of University of Hong Kong,Shenzhen,China[33]The Second Hospital of Hebei Medical University,Shijiazhuang,China[34]Taihe Hospital,Shiyan,China[35]First Hospital of Shanxi Medical University,Taiyuan,China[36]Shanxi Provincial People''s Hospital,Taiyuan,China[37]Tianjin Medical University General Hospital,Tianjin,China[38]The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,China[39]Renmin Hospital of Wuhan University,Wuhan,China[40]Tongji Hospital,Wuhan,China[41]The Second Affiliated Hospital of the Chinese People''s Liberation Army Air Force Medical University,Xi''an,China[42]Xi''an International Medical Center Hospital,Xi''an,China[43]The First Affiliated Hospital of Xiamen University,Xiamen,China[44]Zhongshan Hospital Xiamen University,Xiamen,China[45]Yan''an University Xianyang Hospital,Xianyang,China[46]Yantai Mountain Hospital in Yantai City,Yantai,China[47]The Central Hospital of Yongzhou,Yongzhou,China[48]Zaozhuang Municipal Hospital,Zaozhuang,China[49]Henan Provincial People''s Hospital,Zhengzhou,China[50]The First Affiliated Hospital of Zhengzhou University,Zhengzhou,China[51]Zigong First People''s Hospital,Zigong,China
研究目的：
To evaluate the efficacy and safety of B001 injection in aquaporin-4 antibody positive patients with neuromyelitis optica spectrum disorder.
